fbpx

trial results

Dr Rachel Campbell discusses findings from a new publication for the MOST-S26 study

A new journal has been published by the National Library of Medicine for ANZGOG's MOST-S26 study. The Measure of Ovarian Symptoms and Treatment study (MOST-S26) detected an improvement in symptoms of peripheral neuropathy, psychological [...]

Dr Rachel Campbell discusses findings from a new publication for the MOST-S26 study2021-09-15T00:55:56+10:00

New Publication for the PHAEDRA study (PHAse 2 trial of DuRvalumab in Advanced Endometrial Cancer)  

A new journal has been published by the Journal for ImmunoTherapy of Cancer for ANZGOG's PHAEDRA study. The PHAEDRA study examined the activity of the immunotherapeutic agent durvalumab in women with advanced endometrial cancer that [...]

New Publication for the PHAEDRA study (PHAse 2 trial of DuRvalumab in Advanced Endometrial Cancer)  2021-07-22T23:34:55+10:00

ANZGOG’s OUTBACK Trial Among the Most Important Cervical Cancer Research Advances in the Past Year

A significant international study in cervical cancer treatment, the ANZGOG-led OUTBACK trial will be presented at the 2021 ASCO Annual Meeting Plenary Session to reveal its highly anticipated results. OUTBACK is an academic collaboration [...]

ANZGOG’s OUTBACK Trial Among the Most Important Cervical Cancer Research Advances in the Past Year2021-06-23T03:57:20+10:00
Go to Top